Viewing Study NCT01144260


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2025-12-26 @ 12:44 AM
Study NCT ID: NCT01144260
Status: COMPLETED
Last Update Posted: 2013-05-15
First Post: 2010-06-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Sponsor: CytRx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module